Beone Medicines Ltd. Class A · SSE:688235
Wang Xiaodong sold 38,287 Beone Medicines Ltd. Class A shares (Form 4)
Traded Sep 8, 2026 · Filed Sep 10, 2026
On Sep 8, 2026, Wang Xiaodong (Director, Chair, Scientific Advisory Brd) sold 38,287 Beone Medicines Ltd. Class A shares at an average US$349.10 for US$13.4M under a trading plan, leaving 0 shares. Filed Sep 10, 2026 (Form 4).
- Sold
- 38,287 shares
- Price
- US$349.10 average (US$345.38 to US$351.25)
- Value
- US$13.4M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chair, Scientific Advisory Brd
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | American Depositary Shares | Sale | 1,181 | US$345.38 | 6,079 | Direct |
| Sep 8, 2026 | American Depositary Shares | Sale | 2,841 | US$346.16 | 3,238 | Direct |
| Sep 8, 2026 | American Depositary Shares | Sale | 1,517 | US$347.39 | 1,721 | Direct |
| Sep 8, 2026 | American Depositary Shares | Sale | 1,721 | US$348.01 | 0 | Direct |
| Sep 8, 2026 | American Depositary Shares | Option exercise | 31,027 | US$36.90 | 31,027 | Direct |
| Sep 8, 2026 | American Depositary Shares | Sale | 7,492 | US$348.31 | 23,535 | Direct |
| Sep 8, 2026 | American Depositary Shares | Sale | 10,688 | US$349.28 | 12,847 | Direct |
| Sep 8, 2026 | American Depositary Shares | Sale | 6,569 | US$350.27 | 6,278 | Direct |
| Sep 8, 2026 | American Depositary Shares | Sale | 6,278 | US$351.25 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Wang Xiaodong
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Wang Xiaodong · Jun 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Ball Titus B. · Sep 3, 2026
- Form 4 · Wu Xiaobin · Aug 27, 2026